[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filed a Form 144 reporting an intended sale of 1,762 common shares with an aggregate market value of $41,027.11, expected to occur on 09/16/2025 on the NYSE. The shares were acquired on 09/11/2025 through restricted stock vesting and were received as compensation.

The filer, identified as Amy Vanduyn, previously sold 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11. The filing discloses there are 59,914,473 shares outstanding. The document includes the broker name and address (Fidelity Brokerage Services LLC) and a standard attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Disclosed acquisition method: Shares were acquired via restricted stock vesting and documented as compensation, providing clarity on the origin of the securities
• Broker identified: Sale is routed through Fidelity Brokerage Services LLC, and an approximate sale date and market value are provided, supporting transparency

Negative

• Insider selling activity: The filer sold 19,213 shares in the past three months (640 and 18,573) and proposes to sell an additional 1,762 shares, which could concern some investors
• Relationship to issuer not shown in the provided excerpt, which is typically relevant to assess insider status and regulatory context

Insights

Securities Analyst

TL;DR: Insider intends to sell a small number of vested shares; transaction appears procedural with limited market impact.

The filing reports a proposed sale of 1,762 common shares valued at $41,027.11, acquired via restricted stock vesting on 09/11/2025 and slated for sale on 09/16/2025 through Fidelity on the NYSE. Given outstanding shares of 59,914,473, this disposal represents an immaterial fraction of the float. Recent prior sales by the same person total 19,213 shares generating roughly $581,262, indicating ongoing monetization of vested equity. For investors, this is routine insider selling tied to compensation liquidity rather than a disclosed change in company fundamentals.

Compliance/Risk Analyst

TL;DR: Form 144 provides required Rule 144 disclosure; information appears complete for the reported transaction but omits issuer relationship details.

The submission lists acquisition date, nature of acquisition (restricted stock vesting), payment as compensation, broker details, and recent sales history, aligning with Rule 144 disclosure elements. The filing includes an attestation about absence of undisclosed material adverse information. The record does not explicitly state the filer’s relationship to the issuer in the provided excerpt, which is typically included; if missing from the full filing, that could be an omission to address for full compliance clarity. Overall, this appears to be a routine compliance filing for insider share disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1762	41027.11	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			1762	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amy Vanduyn 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	640	17206.91
Amy Vanduyn 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/25/2025	18573	564055.11

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Phreesia Form 144 (PHR) report for sale?

The filing reports a proposed sale of 1,762 common shares with an aggregate market value of $41,027.11.

When were the shares acquired and how were they obtained?

The shares were acquired on 09/11/2025 via restricted stock vesting and the payment/source is listed as compensation.

When is the approximate sale date and on which exchange will the sale occur?

The approximate sale date is 09/16/2025 and the filing lists the NYSE as the exchange.

Who is the broker handling the sale?

The broker named is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

What insider sales occurred in the past three months by this person?

Prior sales reported: 640 shares on 07/17/2025 for $17,206.91 and 18,573 shares on 08/25/2025 for $564,055.11.

How many shares does Phreesia have outstanding per this filing?

The filing reports 59,914,473 shares outstanding.